Publication:
Trastuzumab deruxtecan in her2-low breast cancer

dc.contributor.coauthorÖzbalak, Murat
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorBirtaş Ateşoğlu, Elif
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:26:44Z
dc.date.issued2022
dc.description.indexedbyWOS
dc.description.issue12
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume387
dc.identifier.eissn1533-4406
dc.identifier.issn0028-4793
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11585
dc.identifier.wos865461700017
dc.language.isoeng
dc.publisherMassachusetts Medical Soc
dc.relation.ispartofNew England Journal of Medicine
dc.subjectMedicine
dc.subjectGeneral
dc.subjectInternal
dc.titleTrastuzumab deruxtecan in her2-low breast cancer
dc.typeLetter
dspace.entity.typePublication
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan
local.contributor.kuauthorBirtaş Ateşoğlu, Elif
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files